Key facts
- This page summarizes Michael S. Abrams's Form 4 filing for Arch Therapeutics, Inc. (ARTHQ).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 08 Jul 2022, 16:57.
Michael S. Abrams - 06 Jul 2022 Form 4 Insider Report for Arch Therapeutics, Inc. (ARTHQ)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- ARTHQ
- Reported as of
- 06 Jul 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Jul 2022, 16:57:10 UTC
- Prior SEC filing
- 01 Oct 2021
- Next SEC filing
- 10 Nov 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Abrams
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael S. Abrams filed Form 4 for Arch Therapeutics, Inc. (ARTHQ) on 08 Jul 2022.
Change
- Previous filing in this sequence was filed on 01 Oct 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ARTH
transaction
Common Stock
Award
- Transaction value
- Shares
- +108,652
- Change %
- Price
- Shares after
- 108,652
- Date
- 06 Jul 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ARTH
transaction
Derivative
Senior Secured Convertible Notes
Award
- Transaction value
- Shares
- +36,000
- Change %
- Price
- Shares after
- $36,000
- Date
- 06 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 787,746
- Exercise price
- Footnotes
- F1, F2
ARTH
transaction
Derivative
Warrants
Award
- Transaction value
- Shares
- +724,346
- Change %
- Price
- Shares after
- 724,346
- Date
- 06 Jul 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 724,346
- Exercise price
- $0.0497
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The shares of common stock, senior secured convertible notes (the "Notes") and warrants were issued to the Reporting Person in connection with a convertible note offering entered into by the Reporting Person and the Issuer (the "Offering"), which Offering was approved by the Issuer's Board of Directors and, in accordance with Rule 16b-3(d)(1) of the Exchange Act (the "Act"), is exempt from Section 16(b) of the Act pursuant to Rule 16b-3(e) promulgated thereunder.
Footnote F2
The Notes become due and payable on January 6, 2024, bear interest at a rate of 10% per annum, are convertible at the option of the holder pursuant to certain provisions with an initial conversion price of $0.0457, contain customary events of default and are subject to certain beneficial ownership limitations.
Footnote F3
Conversion of the warrants is subject to certain beneficial ownership limitations.